Mr. Paul Duffy reports

AI/ML INNOVATIONS ANNOUNCES ADVANCE NOTICE PROVISIONS

AI-ML Innovations Inc. has amended its articles to require that advance notice be given to the company when director nominations are made by shareholders other than through a request for a meeting or through a shareholder proposal, in each case in accordance with the Business Corporations Act.

The amended articles provide a clear process for shareholders to follow for director nominations, and will help ensure that all shareholders receive adequate notice and information about director nominees in order to exercise their voting rights in an informed manner. The amended articles are similar to the advance notice bylaws adopted by many other Canadian public companies.

Among other things, the amended articles fix deadlines by which shareholders must notify the company of director nominations prior to any annual or special meeting of shareholders where directors are to be elected. It also sets forth the information about the proposed nominee that a shareholder must include in the notice for it to be valid.

In the case of an annual shareholder meeting, notice to the company must be given not less than 30 days prior to the date of the annual meeting nor more than 65 days before the date of such meeting. In the event that the annual meeting is to be held on a date that is less than 50 days after the first public announcement of the meeting's date, notice may be given not later than the close of business on the 10th day following such announcement.

In the case of a special meeting of shareholders (which is not also an annual meeting), notice to the company must be given not later than the close of business on the 15th day following the first public announcement of the date of the special meeting.

The amended articles also prescribe the proper written form for a shareholder's notice and provides that the company's board of directors may, in its sole discretion, waive any requirement under these provisions. The amended articles are effective immediately and will be placed before shareholders for approval, confirmation, and ratification at the next annual and special meeting of shareholders of the company. Pursuant to the provisions of the act, the amended articles will cease to be effective unless they are approved, ratified and confirmed by a resolution adopted by a majority of the votes cast by the shareholders of the company at the meeting.

About AI-ML Innovations Inc.

AI-ML Innovations is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. The company's proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment and more effective care. AI-ML's shares trade on the Canadian Securities Exchange (CSE: AIML), the OTCQB Venture Market (AIMLF) and the Frankfurt Stock Exchange (42FB).

We seek Safe Harbor.